Erratum to: Breast Cancer Res Treat (2014) 148:553–561 DOI 10.1007/s10549-014-3144-y
Unfortunately, in the original publication of the article, the number of patients in the eribulin group for the overall population in Fig. 2 was erroneously published as n = 1,602. The correct value should read as n = 1,062.
Footnotes
The online version of the original article can be found under doi:10.1007/s10549-014-3144-y.
